Inhibitory effect of alcohol on ghrelin secretion in normal man

被引:75
作者
Calissendorff, J [1 ]
Danielsson, O
Brismar, K
Röjdmark, S
机构
[1] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabetol, S-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Clin Chem, S-17176 Stockholm, Sweden
[3] Stockholm Soder Hosp, Endocrinol Sect, Dept Med, Stockholm, Sweden
关键词
D O I
10.1530/eje.1.01905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Human appetite is stimulated by alcohol but the underlying mechanism is unknown. It is possible that hunger-stimulating hormones are mediators of this effect of alcohol. Ghrelin stimulates hunger, but how alcohol affects human ghrelin secretion has never been studied before. Objective: To investigate whether alcohol ingestion exerts an acute influence on serum ghrelin concentrations in healthy subjects. Subjects and design: Eight healthy non-obese subjects participated in the study. All were investigated on two occasions (experiments A and 13). Alcohol (0.55 g ethanol/kg body weight) was ingested in experiment A, and drinking-water in experiment B. Venous blood was collected before, and 30 and 60 min after consumption of the drinks. Serum concentrations of ghrelin, cortisol and ethanol were determined and neuropeptide Y (NPY) concentrations were determined in plasma. Results: Alcohol lowered the ghrelin level by 13.9 +/- 5.0% at 30 min and by 17.5 +/- 2.6% at 60 min, in contrast to drinking-water which was without significant effect. Serum levels of cortisol and insulin were similar after alcohol and water as was plasma NPY. Conclusion: Alcohol has an acute inhibitory influence on human ghrelin secretion but no measurable effect on the secretion of NPY and cortisol. Hence, none of these hormones mediate the orexigenic effect of the drug.
引用
收藏
页码:743 / 747
页数:5
相关论文
共 33 条
[1]   HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY [J].
ADRIAN, TE ;
FERRI, GL ;
BACARESEHAMILTON, AJ ;
FUESSL, HS ;
POLAK, JM ;
BLOOM, SR .
GASTROENTEROLOGY, 1985, 89 (05) :1070-1077
[2]   Effects of modified sham feeding on ghrelin levels in healthy human subjects [J].
Arosio, M ;
Ronchi, CL ;
Beck-Peccoz, P ;
Gebbia, C ;
Giavoli, C ;
Cappiello, V ;
Conte, D ;
Peracchi, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) :5101-5104
[3]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[4]   Is decreased leptin secretion after alcohol ingestion catecholamine-mediated? [J].
Calissendorff, J ;
Brismar, K ;
Röjdmark, S .
ALCOHOL AND ALCOHOLISM, 2004, 39 (04) :281-286
[5]   Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects [J].
Chan, JL ;
Bullen, J ;
Lee, JH ;
Yiannakouris, N ;
Mantzoros, CS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :335-343
[6]   Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans [J].
Date, Y ;
Kojima, M ;
Hosoda, H ;
Sawaguchi, A ;
Mondal, MS ;
Suganuma, T ;
Matsukura, S ;
Kangawa, K ;
Nakazato, M .
ENDOCRINOLOGY, 2000, 141 (11) :4255-4261
[7]   Central regulators of food intake [J].
Druce, M ;
Bloom, SR .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2003, 6 (04) :361-367
[8]   The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity [J].
Flint, A ;
Raben, A ;
Ersboll, AK ;
Holst, JJ ;
Astrup, A .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (06) :781-792
[9]   INCREASED FOOD-INTAKE BY NEUROPEPTIDE-Y IS DUE TO AN INCREASED MOTIVATION TO EAT [J].
FLOOD, JF ;
MORLEY, JE .
PEPTIDES, 1991, 12 (06) :1329-1332
[10]   Evidence for inhibition of leptin secretion by catecholamines in man [J].
Fritsche, A ;
Wahl, HG ;
Metzinger, E ;
Renn, W ;
Kellerer, M ;
Häring, H ;
Stumvoll, M .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (05) :415-418